Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/3150
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorTAKAHASHI, P. S. K.
dc.contributor.authorBARRETO, M. R.
dc.contributor.authorBOSSI JR., F.
dc.contributor.authorSOUZA, A. B.
dc.contributor.authorRIBEIRO, E.
dc.contributor.authorFRANCA, G. G.
dc.date.accessioned2013-10-11T21:31:48Z
dc.date.available2013-10-11T21:31:48Z
dc.date.issued2012
dc.identifier.citationDRUG SAFETY, v.35, n.10, p.920-921, 2012
dc.identifier.issn0114-5916
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/3150
dc.description.abstractIntroduction: Vancomycin is indicated to patients who have not responded to treatment with other antibiotics in serious infections caused by organisms susceptible to it and resistant to other antimicrobials, such as methicillin-rcsistant Staphylococcus aureus1. However, over the last five years, many adverse events have been reported with this medicine in the University Hospital of the University of Sao Paulo (HU/USP), such as nephrotoxicity and toxicity related to infusion2. Some critical patients, for example surgical patients with sepsis and severe trauma are generally susceptible to renal failure due to the severity of the underlying disease3. Aim: To analyze adverse events caused by vancomycin. Methods: We conducted a retrospective observational quantitative and qualify study of medical records of patients who had confirmed adverse events occurred with vancomycin in the period from January 2007 to May 2012, at the HU/USP - Brazil. All notifications related to vancomycin were evaluated in the following items: age and sex of patients, type of adverse event and ward where occurred. Results: In this period of time it was confirmed 37 adverse events with vancomycin. Of these cases reported, 75.7% (n = 28) accounted for adults (14 female and 14 male patients). The mean age was 56.4 years. Among these adults, 57.1% were hospitalized at the medical clinic, 21.4% at the surgical clinic and 17.9% at ICU. The other remaining 24.3% (n = 9) of reports occurred in pédiatrie patients and the age ranged from 7 days to 15 years old. These events occurred more frequently in pédiatrie ICU (n = 8) followed by the emergency pédiatrie department (n= 1). The skin events (70.3%) were the most prevalent, comprising signs such as itching, rash, swelling, and Steven-Johnson's syndrome. Secondly, it was notified renal events (13.5%), for instance acute renal failure, interstitial nephritis and parenchymal injury. Thirdly, there were events involved the therapeutic ineffectiveness (10.8%), and hematological and intestinal, with the same frequency (2.7%). Conclusions: In this study, the events were the most frequent skin followed by renal, hematological and intestinal and they occurred more frequently in adult patients admitted to the medical clinic.
dc.language.isoeng
dc.publisherADIS INT LTD
dc.relation.ispartofDrug Safety
dc.rightsrestrictedAccess
dc.titleAdverse Events Related to Vancomycin Use in a University Hospital in Brazil
dc.typeconferenceObject
dc.rights.holderCopyright ADIS INT LTD
dc.description.conferencedateOCT 30-NOV 02, 2012
dc.description.conferencelocalCancun, MEXICO
dc.description.conferencename12th Annual Meeting of the International-Society-of-Pharmacovigilance (ISoP) on New Landscapes for Pharmacovigilance
dc.subject.wosPublic, Environmental & Occupational Health
dc.subject.wosPharmacology & Pharmacy
dc.subject.wosToxicology
dc.type.categorymeeting abstract
dc.type.versionpublishedVersion
hcfmusp.author.externalBARRETO, M. R.:Univ Sao Paulo, Fac Pharm, Sao Paulo, Brazil
hcfmusp.author.externalBOSSI JR., F.:Univ Sao Paulo, Fac Pharm, Sao Paulo, Brazil
hcfmusp.description.beginpage920
hcfmusp.description.endpage921
hcfmusp.description.issue10
hcfmusp.description.volume35
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000309083600098
hcfmusp.publisher.cityAUCKLAND
hcfmusp.publisher.countryNEW ZEALAND
hcfmusp.relation.referenceElyasi S, 2012, WELSH PAED J
hcfmusp.relation.referenceMuppidi K, 2012, ISRN PHARM, P1
hcfmusp.relation.referenceRybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434
dc.description.indexMEDLINE
Appears in Collections:

Comunicações em Eventos - HC/InCor
Instituto do Coração - HC/InCor

Comunicações em Eventos - HU
Hospital Universitário - HU


Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.